Adolor Report. Within forty-five (45) days after the end of ------------- each Calendar Quarter, on a Collaboration Product-by-Collaboration Product basis in the United States, Adolor shall submit to GSK a written report (each, an "Adolor Report") setting forth in reasonable detail the following items during ------------- such Calendar Quarter: (a) Development Expenses incurred by Adolor for each: (i) Adolor Product; and (ii) the OBD Chronic Product and each other GI Product for where Adolor has elected to fund Development Expenses under Section 4.6.5, and where Adolor has not made a Royalty Conversion Election; (b) Marketing Expenses incurred by Adolor for each: (i) Adolor Product; and (ii) the OBD Chronic Product and each other GI Product for where Adolor has elected to fund Development Expenses under Section 4.6.5, and where Adolor has not made a Royalty Conversion Election; (c) Cost of Goods for each Adolor Product in the United States (except for any Cost of Goods separately reimbursed under a supply agreement between the Parties); (d) Royalties, if any, paid by Adolor to Third Parties in accordance with Section 6.6.1;
Appears in 5 contracts
Samples: Collaboration Agreement (Adolor Corp), Collaboration Agreement (Adolor Corp), Collaboration Agreement (Adolor Corp)